CNXUNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends October 31
Conexeu Sciences Inc.
Financials through Q3 FY2026, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026
$3.29+0.23 (+7.52%)
Close on Oct 19, 2026
- Market cap
- $88.74M
- P/E (TTM)
- –
- Dividend yield
- –
About Conexeu Sciences
Orthopedic, Prosthetic & Surgical Appliances & Supplies, SIC 3842
Conexeu Sciences Inc. is listed on Nasdaq under the ticker CNXU, in the SEC industry Orthopedic, Prosthetic & Surgical Appliances & Supplies. It is incorporated in Nevada and its fiscal year ends on October 31. Reported financials on StockData start in fiscal 2024.
Company profile
Company
- Legal name
- Conexeu Sciences Inc.
- Headquarters
- Reno, NV
- Address
- 50 West Liberty Street, Suite 880 89501
- Phone
- (604) 315-4722
- Website
- conexeu.com
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- Incorporated in
- Nevada
- Fiscal year ends
- October 31
Stock & identifiers
- Ticker
- CNXU
- Exchange
- Nasdaq
- IPO date
- May 11, 2026
- Shares outstanding
- 28M, Sep 10, 2026
- Filer category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- SEC CIK
- 2066836
- CUSIP
- 20715F100
- ISIN
- US20715F1003
- EIN
- 00-0000000
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| David Robert Bogart | Chief Commercial Officer, Director | 2,243,750 |
| Miles David Harrison | President and CEO, Director | 237,861 |
| Claudia Itze Chavez-Munoz | Chief Science Officer | 444,111 |
| Stephen Douglas Inouye | CFO, Secretary, and Treasurer | 57,525 |
| Brian Keith Pilcher | Chief Medical Officer | 87,861 |
| Jeffrey Nathan Sharpe | Director | 1,500,000 |
| Lynn Sebastian Purcell | Director | 2,951,848 |
| Andrew Costa | Director | – |
| April Lynn Burke | Director | – |
| Ana Lucia Bastiani-Posner | Director | – |
| Zbigniew Paul Lorenc | Director | 433,323 |
| Aaron Solomon Farberg | Director | 10,869 |
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| May 11, 2026 | IPO | Initial public offering priced (424B4 prospectus) |
| May 11, 2026 | Listing | Registration of securities on an exchange (Form 8-A) |